186 related articles for article (PubMed ID: 17928886)
1. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
[TBL] [Abstract][Full Text] [Related]
2. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
van Grotel M; Meijerink JP; Beverloo HB; Langerak AW; Buys-Gladdines JG; Schneider P; Poulsen TS; den Boer ML; Horstmann M; Kamps WA; Veerman AJ; van Wering ER; van Noesel MM; Pieters R
Haematologica; 2006 Sep; 91(9):1212-21. PubMed ID: 16956820
[TBL] [Abstract][Full Text] [Related]
3. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique.
Cauwelier B; Cavé H; Gervais C; Lessard M; Barin C; Perot C; Van den Akker J; Mugneret F; Charrin C; Pagès MP; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Mozzicconacci MJ; Terré C; Luquet I; Cornillet-Lefebvre P; Laurence B; Plessis G; Lefebvre C; Leroux D; Antoine-Poirel H; Graux C; Mauvieux L; Heimann P; Chalas C; Clappier E; Verhasselt B; Benoit Y; Moerloose BD; Poppe B; Van Roy N; Keersmaecker KD; Cools J; Sigaux F; Soulier J; Hagemeijer A; Paepe AD; Dastugue N; Berger R; Speleman F
Leukemia; 2007 Jan; 21(1):121-8. PubMed ID: 17039236
[TBL] [Abstract][Full Text] [Related]
4. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
Meijerink JP
Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
6. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
[TBL] [Abstract][Full Text] [Related]
8. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
[TBL] [Abstract][Full Text] [Related]
10. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
[TBL] [Abstract][Full Text] [Related]
11. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.
Kimura N; Akiyoshi T; Uchida T; Okamura J; Kozuru M; Nishimura J; Ohyashiki JH; Kikuchi M; Niho Y; Okumura M
Leukemia; 1996 Apr; 10(4):650-7. PubMed ID: 8618442
[TBL] [Abstract][Full Text] [Related]
13. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
14. A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia.
van Vlierberghe P; Meijerink JP; Lee C; Ferrando AA; Look AT; van Wering ER; Beverloo HB; Aster JC; Pieters R
Leukemia; 2006 Jul; 20(7):1245-53. PubMed ID: 16673019
[TBL] [Abstract][Full Text] [Related]
15. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
16. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.
Janssen JW; Ludwig WD; Sterry W; Bartram CR
Leukemia; 1993 Aug; 7(8):1204-10. PubMed ID: 8350619
[TBL] [Abstract][Full Text] [Related]
17. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S
Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529
[TBL] [Abstract][Full Text] [Related]
18. IgH DJ rearrangements within T-ALL correlate with cCD79a expression, an immature/TCRgammadelta phenotype and absence of IL7Ralpha/CD127 expression.
Asnafi V; Beldjord K; Garand R; Millien C; Bahloul M; LeTutour P; Douay L; Valensi F; Macintyre E
Leukemia; 2004 Dec; 18(12):1997-2001. PubMed ID: 15483677
[TBL] [Abstract][Full Text] [Related]
19. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy.
Asnafi V; Beldjord K; Libura M; Villarese P; Millien C; Ballerini P; Kuhlein E; Lafage-Pochitaloff M; Delabesse E; Bernard O; Macintyre E
Blood; 2004 Dec; 104(13):4173-80. PubMed ID: 15054041
[TBL] [Abstract][Full Text] [Related]
20. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
Breit TM; Wolvers-Tettero IL; van Dongen JJ
Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
